<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<records>
   <record>
      <language>eng</language>
      <journalTitle>Journal of Medical Research and Health Sciences</journalTitle>
      <eissn>2589-9031</eissn>
      <publicationDate/>
      <volume>4</volume>
      <startPage/>
      <doi>https://doi.org/10.15520/jmrhs.v4i6.356</doi>
      <publisherRecordId/>
      <documentType>article</documentType>
      <title language="eng">Shrinkage of Spleen in Sickle Cell Thalassemia: A rare case report</title>
      <authors/>
      <affiliationsList/>
      <abstract language="eng"> The most prevalent monogenic gene disorder caused by defective hemoglobin in the blood is thalassemia. Splenectomy (Total/partial) is considered to be the alternative treatment method based on hypersplenism or iron overload and is an inherited-autosomal-recessive disorder. In South Asia, the far east, the Middle East, and Eastern Mediterranean nations, it is more prevalent. Over 40,000 children are born with Thalassemia every year1.

</abstract>
      <fullTextUrl format="pdf">.pdf</fullTextUrl>
      <keywords language="eng"/>
   </record>
</records>